Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for the second quarter ended ...

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments. Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net ...

This launch marks the first medical cannabis products to be grown in Germany by Aphria RX under the newly issued medical cannabis cultivation license under MedCanG. On July 15, 2024, Tilray ...

Medical Marijuana Market is estimated to be valued at USD 22.34 Bn in 2024 and is expected to reach USD 56.27 Bn by 2031, exhibiting a CAGR of 14.1%. BURLINGAME, CA, UNITED STATES, January 6, 2025 ...

Tilray Brands has expanded its US (Beer / Delta-9 THC) and German operations (Medical Cannabis). Find out why I continue my Hold rating on TLRY stock.

Tilray Brands, Inc. NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German ...

In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against the other best cannabis stocks to invest in. The history of cannabis cultivation in America ...

I have been negative on Tilray Brands (NASDAQ:TLRY) (TSX:TLRY:CA) rather consistently for a long time, and I am upgrading it now from Strong Sell to Neutral. I last wrote about it in early ...